These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8304707

  • 1. [Methylprednisolone versus prednisolone methylsulfobenzoate in pemphigoid: a comparative multicenter study].
    Dreno B, Sassolas B, Lacour P, Montpoint S, Lota I, Giordano F, Royer P.
    Ann Dermatol Venereol; 1993; 120(8):518-21. PubMed ID: 8304707
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day. A multicenter randomized study].
    Morel P, Guillaume JC.
    Ann Dermatol Venereol; 1984; 111(10):925-8. PubMed ID: 6395773
    [Abstract] [Full Text] [Related]

  • 3. High-dose methylprednisolone in the treatment of bullous pemphigoid.
    Siegel J, Eaglstein WH.
    Arch Dermatol; 1984 Sep; 120(9):1157-65. PubMed ID: 6383221
    [Abstract] [Full Text] [Related]

  • 4. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
    Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, Vaillant L, D'Incan M, Plantin P, Bedane C, Young P, Bernard P, Bullous Diseases French Study Group.
    N Engl J Med; 2002 Jan 31; 346(5):321-7. PubMed ID: 11821508
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of prednisone and prednisolone in bullous pemphigoid patients.
    Chosidow O, Etienne SD, Diquet B, Vandermeersch V, Vu-Thi-My-Le C, Herson S, Puech AJ.
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep 31; 29(9):376-80. PubMed ID: 1938000
    [Abstract] [Full Text] [Related]

  • 6. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M, Hashimoto T, Dykes PJ, Nishikawa T.
    Clin Exp Dermatol; 1996 Jan 31; 21(1):23-7. PubMed ID: 8689764
    [Abstract] [Full Text] [Related]

  • 7. Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid.
    Guillaume JC, Vaillant L, Bernard P, Picard C, Prost C, Labeille B, Guillot B, Foldès-Pauwels C, Prigent F, Joly P.
    Arch Dermatol; 1993 Jan 31; 129(1):49-53. PubMed ID: 8420491
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of interferon-gamma in patients with refractory bullous pemphigoid.
    Nakama T, Ishii N, Ono F, Hamada T, Yasumoto S, Hashimoto T.
    J Dermatol; 2007 Nov 31; 34(11):737-45. PubMed ID: 17973812
    [Abstract] [Full Text] [Related]

  • 9. The serum levels of sE-selectin are increased in patients with bullous pemphigoid or pemphigus vulgaris. Correlation with the number of skin lesions and recovery after corsticosteroid therapy.
    D'Auria L, Cordiali Fei P, Pietravalle M, Ferraro C, Mastroianni A, Bonifati C, Giacalone B, Ameglio F.
    Br J Dermatol; 1997 Jul 31; 137(1):59-64. PubMed ID: 9274626
    [Abstract] [Full Text] [Related]

  • 10. Bullous pemphigoid--a report of 86 cases from Taiwan.
    Chang YT, Liu HN, Wong CK.
    Clin Exp Dermatol; 1996 Jan 31; 21(1):20-2. PubMed ID: 8689763
    [Abstract] [Full Text] [Related]

  • 11. [Therapy of bullous pemphigoid with erythromycin].
    Mensing H, Krausse S.
    Med Klin (Munich); 1990 Aug 15; 85(8):481-4. PubMed ID: 2233601
    [Abstract] [Full Text] [Related]

  • 12. Long term plasma exchange therapy in bullous pemphigoid.
    Guillot B, Donadio D, Guilhou JJ, Meynadier J.
    Acta Derm Venereol; 1986 Aug 15; 66(1):73-5. PubMed ID: 2424224
    [Abstract] [Full Text] [Related]

  • 13. Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases.
    Schmidt E, Kraensel R, Goebeler M, Sinkgraven R, Bröcker EB, Rzany B, Zillikens D.
    Cutis; 2005 Sep 15; 76(3):205-9. PubMed ID: 16268266
    [Abstract] [Full Text] [Related]

  • 14. Bullous pemphigoid refractory to recommended dosage of prednisolone in a dog.
    Turnwald GH, Ochoa R, Barta O.
    J Am Vet Med Assoc; 1981 Sep 15; 179(6):587-91. PubMed ID: 7021508
    [Abstract] [Full Text] [Related]

  • 15. Bullous pemphigoid presenting as generalized pruritus: observations in six patients.
    Alonso-Llamazares J, Rogers RS, Oursler JR, Calobrisi SD.
    Int J Dermatol; 1998 Jul 15; 37(7):508-14. PubMed ID: 9679691
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
    Bernard P, Reguiai Z, Tancrède-Bohin E, Cordel N, Plantin P, Pauwels C, Vaillant L, Grange F, Richard-Lallemand MA, Sassolas B, Roujeau JC, Lok C, Picard-Dahan C, Chosidow O, Vitry F, Joly P.
    Arch Dermatol; 2009 May 15; 145(5):537-42. PubMed ID: 19451497
    [Abstract] [Full Text] [Related]

  • 17. Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid.
    Budimir J, Mihić LL, Situm M, Bulat V, Persić S, Tomljanović-Veselski M.
    Acta Clin Croat; 2008 Mar 15; 47(1):13-8. PubMed ID: 18714642
    [Abstract] [Full Text] [Related]

  • 18. Development of a bullous pemphigoid after split-skin grafting.
    Ghura HS, Johnston GA, Milligan A.
    Br J Plast Surg; 2001 Jul 15; 54(5):447-9. PubMed ID: 11428779
    [Abstract] [Full Text] [Related]

  • 19. [Pemphigoid in children].
    Misery L, Jay P, Kanitakis J, Chouvet B, Cozzani E, Faure M, Claudy A.
    Ann Dermatol Venereol; 1994 Jul 15; 121(9):623-5. PubMed ID: 7771729
    [Abstract] [Full Text] [Related]

  • 20. Prediction of survival for patients with bullous pemphigoid: a prospective study.
    Joly P, Benichou J, Lok C, Hellot MF, Saiag P, Tancrede-Bohin E, Sassolas B, Labeille B, Doutre MS, Gorin I, Pauwels C, Chosidow O, Caux F, Estève E, Dutronc Y, Sigal M, Prost C, Maillard H, Guillaume JC, Roujeau JC.
    Arch Dermatol; 2005 Jun 15; 141(6):691-8. PubMed ID: 15967914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.